Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:KEL
TSX:KELOil and Gas

Kelt Exploration (TSX:KEL) Valuation Check After Strong 2025 Revenue And Net Income Results

Kelt Exploration (TSX:KEL) just released full year 2025 results, providing fresh insight into how the business is performing. The update highlights changes in revenue, net income and earnings per share. See our latest analysis for Kelt Exploration. The latest full year results come after a period of firming momentum, with a 30-day share price return of 10.49% and a 90-day share price return of 24.97% at a last close of CA$9.06. Over a longer horizon, the 1-year total shareholder return of...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

A Look At PayPal Holdings (PYPL) Valuation After CEO Exit Weak Results And Investor Lawsuits

PayPal Holdings (PYPL) is in the spotlight after weak Q4 and full year 2025 results, a sudden CEO ousting, and a wave of securities class action lawsuits focused on its core Branded Checkout growth messaging. See our latest analysis for PayPal Holdings. At a share price of US$44.36, the recent 1 day share price return of a 2.66% decline and 7 day share price return of a 6.88% decline sit against a 90 day share price return of a 28.06% decline and 1 year total shareholder return of a 33.35%...
HLSE:WRT1V
HLSE:WRT1VMachinery

A Look At Wärtsilä (HLSE:WRT1V) Valuation After Approving A Higher 2025 Dividend And Extraordinary Payout

Wärtsilä Oyj Abp (HLSE:WRT1V) drew fresh attention on 12 March 2026 as shareholders approved a total dividend of €1.06 per share for 2025, combining a base payout with an extraordinary distribution. See our latest analysis for Wärtsilä Oyj Abp. The higher total payout and refreshed board structure come after a steady pick up in momentum, with a 90 day share price return of 10.53% and a 3 year total shareholder return of 343.05%, based on the current €33.6 share price. If Wärtsilä’s mix of...
NYSE:SEE
NYSE:SEEPackaging

Sealed Air Debt Redemptions Could Reshape Leverage And Investor Risk Profile

Sealed Air (NYSE:SEE) has announced its intention to redeem multiple senior notes, subject to the closing of a pending transaction. The planned redemptions would retire certain outstanding debt instruments once the transaction is completed. The company has outlined the expected redemption terms ahead of closing to give bondholders and shareholders clarity on next steps. For investors watching Sealed Air, the focus now is on how this conditional redemption plan fits with the company’s...
NasdaqGM:ANIP
NasdaqGM:ANIPPharmaceuticals

How ANI’s Reaffirmed 2026 Guidance and Rare Disease Push Will Impact ANI Pharmaceuticals (ANIP) Investors

ANI Pharmaceuticals, Inc. recently reported fourth-quarter 2025 sales of US$247.06 million, up from US$190.57 million a year earlier, and moved from a net loss to net income of US$27.49 million. Alongside reaffirmed 2026 revenue guidance of US$1.06 billion to US$1.12 billion, management highlighted rare disease therapies and Cortrophin Gel as central to the company’s growth plans. Now we'll examine how ANI Pharmaceuticals' reaffirmed 2026 revenue guidance and rare disease expansion shape the...
ASX:CSL
ASX:CSLBiotechs

Did CSL's US$1.5 Billion US Plasma Build-Out Just Shift CSL's (ASX:CSL) Investment Narrative?

CSL has recently broken ground on a US$1.50 billion expansion of its Kankakee, Illinois plasma-therapy manufacturing facility, adding at least 300 new pharmaceutical jobs and incorporating its patented Horizon 2 process to increase immunoglobulin and albumin production capacity by 2031. This large-scale build-out not only deepens CSL’s U.S. manufacturing footprint but also advances its goal of end-to-end plasma processing within the United States, which may be important for supply resilience...
NYSE:ESE
NYSE:ESEMachinery

A Look At ESCO Technologies (ESE) Valuation After Strong Multi Year Returns And Recent Share Price Pullback

What ESCO Technologies investors are looking at today ESCO Technologies (ESE) trades around $266.43, with recent returns showing a 1 day decline of 1.6% and a 4.3% drop over the past month, following gains over the past 3 months and year. See our latest analysis for ESCO Technologies. Short term momentum has cooled, with a 1 month share price return of a 4.3% decline. However, the 1 year total shareholder return of 70.15% suggests longer term sentiment has remained strong, likely reflecting...
NYSE:AFL
NYSE:AFLInsurance

Aflac Partnership With Empower Agents Meets Undervalued Share Price Story

Aflac (NYSE:AFL) has entered into a new partnership with Empower Brokerage. The agreement authorizes more than 8,000 independent Empower agents to offer Aflac insurance products. The collaboration was recently announced and expands Aflac's distribution footprint across the independent agent channel. Aflac, known for its supplemental health and life insurance offerings, is leaning into distribution partnerships as the insurance sector adapts to changing customer expectations and sales...
NasdaqGS:MZTI
NasdaqGS:MZTIFood

Is Marzetti (MZTI) Using Cleaner-Label Dressings to Sharpen Its Brand and Pricing Power?

The Marzetti Company recently introduced its new Marzetti Simply Dressed salad dressings line, featuring six flavors with simplified ingredient lists that will replace the prior Marzetti Simply products on grocery shelves nationwide. This shift toward a cleaner-label, flavor-focused range suggests Marzetti is actively aligning its core dressings portfolio with health-conscious consumer preferences and premium at-home eating trends. With this cleaner-label Simply Dressed relaunch, we’ll now...
NYSE:WOR
NYSE:WORMachinery

Is Worthington Enterprises (WOR) Pricing Look Attractive After Recent Share Price Pullback

If you are looking at Worthington Enterprises and wondering whether the current share price reflects its true value, this article will walk you through what the numbers are actually saying. The stock last closed at US$46.99, after a 7 day return of a 9.9% decline, a 30 day return of an 18.8% decline, a year to date return of a 9.6% decline, but a 1 year return of 18.8% and a 3 year return of 47.2% that sits ahead of its 5 year return of 16.3%. Recent coverage around Worthington Enterprises...
XTRA:SIE
XTRA:SIEIndustrials

A Look At Siemens (XTRA:SIE) Valuation After Joining The DOE’s Genesis Mission

Siemens (XTRA:SIE) has been thrust into the spotlight after signing a Memorandum of Understanding with the U.S. Department of Energy for the Genesis Mission, a federal effort to modernize scientific infrastructure using advanced AI and digital systems. See our latest analysis for Siemens. Siemens’ latest agreement with the U.S. Department of Energy comes after a run of AI and hydrogen related announcements, including the Questa One Agentic Toolkit launch and ongoing share buybacks. This has...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

Assessing Merit Medical Systems (MMSI) Valuation After Recent Share Price Weakness

Merit Medical Systems Stock Moves After Recent Performance Shift Merit Medical Systems (MMSI) has drawn fresh attention after a stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. See our latest analysis for Merit Medical Systems. At a share price of US$68.17, Merit Medical Systems is coming off a sharp 21.37% 3 month share price decline and a 30.20% 1 year total shareholder return loss, although the 5 year...
NasdaqGS:SATS
NasdaqGS:SATSMedia

Is It Time To Reconsider EchoStar (SATS) After Its Sharp Multi‑Year Share Price Surge

If you are looking at EchoStar and wondering whether the current share price still offers value, this article will walk through what the numbers actually say rather than the headlines. EchoStar shares last closed at US$107.71, after a 2.8% decline over 7 days and a 6.9% decline over 30 days, set against a 308.1% return over 1 year and a 477.5% return over 3 years. These price moves sit against a backdrop of ongoing investor interest in the company and its position in the media and satellite...
CNSX:HG
CNSX:HGChemicals

HydroGraph Clean Power’s (CNSX:HG) New Warrant Financing: Tactical Lifeline Or Dilutive Detour?

HydroGraph Clean Power Inc. recently reported first-quarter 2025 results showing sales of about US$19,685 and a wider net loss of US$3.15 million, alongside a basic loss per share from continuing operations of US$0.01. A few days later, the company closed a private placement, paying its agent a tiered cash commission and issuing broker warrants exercisable at C$5.63 for 36 months, highlighting its current focus on access to capital. With these fresh earnings and the completion of a...
TSX:EMP.A
TSX:EMP.AConsumer Retailing

Empire E Commerce Reset Weighs On Earnings But Valuation Signals Upside

Empire Company Limited booked a CA$746 million impairment related to its e-commerce operations, which resulted in a net loss for the quarter. The company is closing its Calgary Customer Fulfilment Centre as part of an overhaul of its online grocery model. Empire is expanding third party delivery partnerships, including a new arrangement with DoorDash, while highlighting adjusted earnings growth. For investors watching TSX:EMP.A, this update marks a clear reset in how Empire approaches...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Enphase Energy (ENPH) Valuation Check After Earnings Beat Product Launches And New Partnership Announcements

Enphase Energy (ENPH) has been back in focus after its Q4 EPS of $0.71 topped expectations, aided by 21% sequential U.S. sell through growth and the U.S. launch of IQ9 Commercial Microinverters. See our latest analysis for Enphase Energy. At a share price of US$43.34, Enphase has had a mixed run, with a 31.29% 90 day share price return and a 28.41% year to date share price return, yet a 25.89% 1 year total shareholder return decline pointing to pressure over a longer stretch. If this story...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall

In February 2026, Travere Therapeutics reported past fourth quarter and full-year results showing strong U.S. net product sales growth driven by FILSPARI, while also flagging an expected US$25,000,000 sales-based milestone from Mirum Pharmaceuticals in the first half of 2026. This combination of robust FILSPARI performance and upcoming milestone income highlights how Travere’s rare kidney disease franchise is increasingly central to its revenue mix. With FILSPARI’s sales strength now...
XTRA:S92
XTRA:S92Electrical

SMA Solar Technology (XTRA:S92) Valuation Check After New 2026 Sales Guidance Update

New 2026 guidance puts SMA Solar Technology in focus SMA Solar Technology (XTRA:S92) has put fresh 2026 sales guidance on the table, expecting SMA Group revenue between €1,475 million and €1,675 million, anchored to currently known trade and geopolitical conditions. The company also flagged that any shift in trade barriers or geopolitical tensions could lead to updated assumptions. Investors now have a clearer reference range while staying alert to potential revisions. See our latest analysis...
NYSE:CRS
NYSE:CRSAerospace & Defense

Did Technical Momentum, Earnings Revisions, and Senator Mullin’s Trades Just Shift Carpenter Technology's (CRS) Investment Narrative?

In recent days, Carpenter Technology has drawn attention as technical analysts highlighted the stock moving above its 20-day moving average while analysts raised earnings estimates for the current fiscal year. An added angle is the scrutiny around Senator Markwayne Mullin’s recent share purchases in Carpenter Technology, given his role on the Senate Armed Services Committee and pending nomination to lead the Department of Homeland Security, which raises fresh questions about potential...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Is It Time To Revisit Axsome Therapeutics (AXSM) After Recent Share Price Weakness

If you are wondering whether Axsome Therapeutics shares are still offering value at around US$159.50, it helps to step back and look at what the current price actually implies. The stock has seen mixed returns, with a 2.8% decline over the last 7 days and a 12.9% decline over the last 30 days, while still sitting on a 33.5% return over 1 year, 157.5% over 3 years, and 134.3% over 5 years. Recent attention on Axsome Therapeutics has focused on its pipeline progress and broader sentiment...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Is It Time To Reconsider Arch Capital Group (ACGL) After The Recent Share Price Pullback

If you are wondering whether Arch Capital Group is attractively priced or already fully valued, you are not alone. This article is designed to help you make sense of where the current share price sits. The stock last closed at US$94.22, with returns of 0.4% year to date and 4.2% over the past year. The 3 year and 5 year returns sit at 50.0% and 163.3%, even after recent 7 day and 30 day declines of 2.9% and 3.7%. Recent coverage has focused on Arch Capital Group's position in the insurance...
HLSE:NOKIA
HLSE:NOKIACommunications

Nokia’s AI RAN Alliances Test Whether Recent Share Momentum Is Justified

Nokia Oyj (HLSE:NOKIA) has announced a series of AI driven Radio Access Network and automation partnerships with Telia Finland, TIM Brasil, Deutsche Telekom, Ericsson, NVIDIA, and Palo Alto Networks. The company is rolling out new AI powered 5G network deployments, AI native RAN solutions, and joint platforms focused on automation, security, and monetization. Nokia has also introduced energy efficient, AI ready radio hardware designed to support more autonomous, cloud native mobile...
NYSE:LUV
NYSE:LUVAirlines

Is It Time To Reassess Southwest Airlines (LUV) After The Recent Share Price Pullback

If you are wondering whether Southwest Airlines at around US$41.85 is still offering value after a strong run, you are not alone. This article will help you frame that question clearly using several valuation tools. The stock is up 41.8% over the past year and 50.4% over three years, even though the last month saw a 21.6% decline and the last week a further 11.2% drop. These moves can change how the market is pricing its potential and risk. Recent headlines around Southwest have focused on...
TSE:7201
TSE:7201Auto

Is There Now An Opportunity In Nissan Motor (TSE:7201) After Recent Share Price Weakness

If you are wondering whether Nissan Motor's current share price reflects its true worth, you are not alone, many investors are asking the same question as they reassess the stock. The shares recently closed at ¥381.4, with a 2.1% gain over the last 7 days contrasting with a 6.8% decline over 30 days and a 10.2% decline over 1 year, which can change how investors think about both upside and risk. Recent headlines around Nissan often focus on its position in the global auto sector and how it...